Repros Therapeutics Inc Stock

Stocks

18-01-26	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
17-12-15	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
17-12-12	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
17-12-12	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
17-12-12	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

15-04-02	Apple : Les valeurs à suivre sur les marchés américains
15-04-02	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	-2.13%	-2.24%	+1.41%	+13.19%	49.24B
REVOLUTION MEDICINES, INC.	-0.65%	-2.28%	+456.55%	+568.23%	43.3B
BEONE MEDICINES AG	-3.08%	-0.90%	+11.44%	+69.07%	40.48B
IQVIA HOLDINGS INC.	-0.78%	+0.53%	+26.70%	+9.02%	39.75B
CELLTRION, INC.	0.00%	+3.59%	+20.51%	+48.00%	32.67B
ASCENDIS PHARMA A/S	-0.10%	-4.33%	-	-	16.23B
MEDPACE HOLDINGS, INC.	-0.37%	-1.83%	+26.43%	+118.31%	16.24B
EUROFINS SCIENTIFIC SE	+0.49%	+0.92%	+4.32%	+22.16%	14.04B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.61%	+4.95%	+80.18%	+29.43%	13.43B
Average	-0.73%	+2.30%	+78.44%	+109.68%	29.49B
Weighted average by Cap.	-1.13%	+2.71%	+94.72%	+130.86%